Featured Posts
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring a…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing. That…
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM) and…
Search Posts
Citation
FDA Drug approval delays; new drug called Provenge
Newsletter
Healthy Eating, Big Labor Fights Itself and the War on Mining
A new Food and Drug Administration study sparks debate over the health benefits of eating fish. Factions of the labor union known as UNITE-HERE fight…
Study
The Case for Compensating Live Organ Donors
Full Document Available in PDF Conflicting opinions on the ethics of organ…
Newsletter
Celebrating Earth Day, the FDA Drags Its Feet and Health Scares Debunked
CEI releases a new video titled “Humans Make Earth Day Better.” Promising anti-cancer drug Provenge languishes in the federal approval process despite mounting evidence of…
Comment
CEI Comments on Draft FDA Risk-Benefit Assessment of Fish Consumption
CEI applauds the FDA's even-handed approach.
News Release
Good News, But Prostate Cancer Patients Still Waiting
Sunday’s meeting of the American Association of Cancer Research saw new hope for prostate cancer patients, as researchers announced very favorable results for the drug…